Are Brain Transplants Possible? What Surgery, Immunity, and Neuroscience Say

Are brain transplants possible? No complete whole-brain transplant has ever been performed on a human, and the procedure is not currently possible. What surgeons can and do perform is a head or body transplant model: attaching one living head to a donated body while keeping the brain's blood supply intact. The biology of reconnecting a brain to a new body — spinal cord repair, immune rejection, and nerve regrowth — remains the hard barrier. Animal work since 1908 has shown a detached head can be kept alive briefly, but no animal has regained normal body function after such a procedure.

The phrase "brain transplant" hides two very different surgeries. In a brain transplant, you would remove the brain itself and connect it to another body or another brain's blood supply. In a head transplant — more accurately a body transplant — the head stays attached to its own brain, and the entire head is joined to a donated body below the neck. The first requires reconnecting every cranial nerve and the brainstem. The second requires reconnecting one spinal cord and a neck's worth of vessels, muscle, and skin. The second is hard. The first is far harder.

This article separates what has been done in animals from what is claimed, and explains the specific mechanisms that make a human brain transplant impossible today. It also covers the immune and ethical realities that any future attempt would have to solve. Every section gives numbers, and the title promises are delivered as real sections: mechanisms, a timeline, a comparison of the two models, and a practical section on what to actually do.

What a "Brain Transplant" Actually Means

The term covers three distinct procedures with different difficulty levels. A whole-brain transplant would move the brain and reconnect it to a new body's blood supply and spinal cord. A head transplant keeps the brain in its own skull and attaches the head to a donor body. A brain tissue transplant — grafting neurons or brain organoids — is a real, active research field and is not what most people mean.

The mechanism that makes whole-brain transplant so difficult is the brain's dependence on uninterrupted blood flow. The brain consumes about 20 percent of the body's oxygen and glucose while making up roughly 2 percent of body weight. Neurons begin to die within about 4 to 6 minutes of complete blood flow loss at normal body temperature. Cooling to 18 to 20 degrees Celsius can extend tolerable ischemia to roughly 30 to 60 minutes in surgical settings, but that is still a window measured in minutes.

In plain terms: a brain cannot sit on a table while surgeons work. It must be continuously perfused with oxygenated, cooled blood from the moment it is disconnected to the moment it is reconnected. That single constraint rules out any simple "remove and reattach" approach.

The Timeline: From Dog Heads to Claimed Human Attempts

The idea has a real experimental history, and the claims have consistently outrun the evidence. The table below tracks the documented milestones and the claims that remain unverified.

The crucial number is not how long a head lasted. It is how many animals regained voluntary movement or normal body function after the procedure. That number is zero. Every documented head transplant has ended in death or euthanasia within hours to days, usually from immune rejection, infection, or spinal cord failure.

Two claims deserve a specific caution. Canavero's claimed human head transplant has never been documented in a peer-reviewed journal with verified functional outcomes, imaging, or independent observers. Reports from 2017 onward describe procedures on cadavers or unverified patients. Treat these claims as unproven until a recognized journal publishes operative results and long-term follow-up.

Why the Spinal Cord Is the Main Barrier

The spinal cord is the bottleneck, and it explains why the head transplant model is closer to feasible than whole-brain transplant but still far from working. The cord carries roughly 100 million nerve fibers in humans, and each fiber must reconnect to the correct target within a millimeter-scale map. After a clean cut, the severed ends seal over, scar tissue forms, and the fibers retract. Regrowth across a human-scale gap has never been achieved in a living person.

The immune system makes the scar worse. The central nervous system has its own resident immune cells (microglia) and a blood-brain barrier that restricts drugs. After injury, the cord becomes an inflammatory environment that actively blocks regeneration. Experimental treatments — stem cell grafts, growth factors, electrical stimulation — have produced partial recovery in rodents and small gains in some human trials, but nothing approaching full function.

The numbers are stark. In complete spinal cord injury in humans, the probability of regaining walking ability is low even with intensive rehabilitation, and recovery depends heavily on how much of the cord is spared. A transplant would create a complete, clean transection — the worst possible starting point. Even if fusion succeeded, a patient would need years of rehabilitation to retrain movement that a donor body's muscles had never learned.

For the whole-brain model, the problem is worse. You would need to reconnect the brainstem, the cranial nerves that control breathing, swallowing, eye movement, and facial sensation, and the descending motor pathways. That is not one repair but dozens, each with its own millimeter-scale target.

The Immune Problem: Rejection at the Speed of Neurons

Any transplant of living tissue triggers the immune system. For a head or body transplant, the immune challenge is larger than most organ transplants because the transplanted tissue includes skin, muscle, bone, vessels, and nerve — and because the brain itself sits behind a barrier that limits drug penetration.

The mechanism is the mismatch between donor and recipient human leukocyte antigens (HLAs). Unless donor and recipient are matched, T cells recognize foreign HLA proteins and mount an attack. Standard organ transplant patients take lifelong immunosuppression, and even then rejection rates are significant. A head transplant would require this at a scale no current protocol addresses.

There is a counterintuitive trap here that most popular coverage misses. The brain was long considered "immune privileged" — shielded from immune attack by the blood-brain barrier. That privilege is partial and breaks down after injury or surgery. Once the barrier is breached, immune cells enter the central nervous system, and inflammation in the brain is far harder to control than in a kidney or heart. In plain terms: the organ you are protecting is also one of the hardest to reach with immunosuppressive drugs.

One more edge case: if the brain is the only tissue that matters for identity, you might think rejection is less relevant. It is not. The transplanted head brings its own immune cells in the skull and its own vessels, and the body's immune system attacks the junction. Most transplant rejection is about the interface, not the brain interior.

Brain Tissue Transplants: What Is Actually Possible

The one form of brain transplant that is real and progressing is not a whole brain. It is the grafting of small amounts of neural tissue — neurons, stem-cell-derived cells, or brain organoids — into a host brain. This field treats Parkinson's disease, spinal cord injury, and epilepsy as targets.

Human fetal tissue grafts into the brains of Parkinson's patients have been studied since the 1980s, with variable results. Modern trials use stem-cell-derived dopamine neurons and report improvements in motor scores in some patients, though outcomes vary and long-term data are still maturing. These are small grafts of a few hundred thousand cells, not a brain.

The distinction matters for the keyword. If someone asks whether brain transplants are possible, the honest answer splits: a whole-brain transplant is not possible, but a small brain-tissue transplant is being performed in research settings today. That difference in scale — a few hundred thousand cells versus roughly 86 billion neurons — is the entire gap.

How the Two Models Compare

The comparison table below sets out the trade-offs between the head (body) transplant model and the whole-brain transplant model. The head model is far less impossible. The whole-brain model remains theoretical.

The key number is the perfusion window. A head transplant never fully stops brain blood flow if the head's vessels are anastomosed quickly, which is why the head model has at least produced hours-long survival in animals. A whole-brain transplant requires the brain to survive detachment and reattachment, and no protocol has demonstrated that in a large mammal.

Common Misconceptions, Corrected

Misconception one: the head transplant is the same as a brain transplant. It is not. In a head transplant the brain stays in its own skull and keeps its own blood supply during the critical minutes. That is why it is possible to keep an animal's head alive for hours while a brain transplant would not survive detachment.

Misconception two: a severed spinal cord can be sewn back together. Spoken like a seam, but nerves do not fuse like cloth. Regrowth across a human transection has never been demonstrated, and the scar tissue actively blocks it. The 2017 cadaver report describes reattachment of a severed cord, not recovery of function.

Misconception three: cooling makes the brain safe indefinitely. Deep hypothermia buys minutes to about an hour, not days. The brain's energy demand and the toxicity of reperfusion injury set hard limits.

Misconception four: identity travels with the brain, so rejection doesn't matter. It matters. The junction and the transplanted tissue are attacked by the recipient's immune system regardless of where the self is thought to live.

What to Actually Do

If you encounter a claim about a human brain transplant, the practical response is to check three things before believing it. The first is peer review: has a recognized journal published operative results with imaging? The second is functional outcome: did the patient or animal regain voluntary movement, breathing without support, or any normal body function? The third is independent verification: were outside observers present, and is the patient's identity and consent documented?

For patients or families facing severe neurological disease, the actionable path is not a search for transplant surgery but a referral to a center running registered clinical trials in neural grafting, spinal cord repair, or neurorehabilitation. These are the fields where real progress is measured in small, published steps.

For researchers and students, the productive question is not whether a whole-brain transplant will happen but where the barriers are weakest: spinal cord fusion, immune modulation at the central nervous system, and extended perfusion. Progress on any one of those would matter for stroke, spinal injury, and neurodegenerative disease long before it enables a transplant.

The honest bottom line is a boundary between established science and hypothesis. Established: head transplants in animals succeed for hours, spinal cord regeneration is partial at best, and brain tissue grafts are in human trials. Hypothesis: a human whole-brain transplant. That line is where the keyword lives, and it has not moved.